Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYC overexpression + IDH2 mutation
i
Other names:
MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, IDH2, Isocitrate Dehydrogenase (NADP(+)) 2, Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial, Isocitrate Dehydrogenase 2 (NADP+), Mitochondrial, Isocitrate Dehydrogenase [NADP], Mitochondrial, Oxalosuccinate Decarboxylase, NADP(+)-Specific ICDH, ICD-M, IDH, IDP, MNADP-IDH, D2HGA2, IDHM, IDPM
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4609
;
3418
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MYC amplification (29)
MYC amplification + HER-2 amplification (1)
MYC amplification (29)
MYC amplification + HER-2 amplification (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYC overexpression + IDH2 mutation
Acute Myelogenous Leukemia
MYC overexpression + IDH2 mutation
Acute Myelogenous Leukemia
enasidenib
Resistant: C3 – Early Trials
enasidenib
Resistant
:
C3
enasidenib
Resistant: C3 – Early Trials
enasidenib
Resistant
:
C3
MYC overexpression + IDH2 mutation
Acute Myelogenous Leukemia
MYC overexpression + IDH2 mutation
Acute Myelogenous Leukemia
ivosidenib
Resistant: C3 – Early Trials
ivosidenib
Resistant
:
C3
ivosidenib
Resistant: C3 – Early Trials
ivosidenib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.